---
title: "SNBL Revamps Top Management to Drive Long-Term Growth"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/284716774.md"
description: "Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) has announced a leadership reshuffle, appointing Hideyuki Hirama as Representative President and Ryoichi Nagata as Representative Chairman, pending shareholder approval on June 26, 2026. This restructuring aims to enhance management for sustainable growth, with an expanded board and new appointments, including Masato Nishie as corporate officer and Naohiro Tsubaru as Honorary Senior Director. The changes reflect SNBL's strategy to improve oversight and competitiveness in the biomedical market. Analysts rate the stock as a Buy with a target price of Yen1780.00."
datetime: "2026-04-30T07:27:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/284716774.md)
  - [en](https://longbridge.com/en/news/284716774.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/284716774.md)
---

# SNBL Revamps Top Management to Drive Long-Term Growth

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Shin Nippon Biomedical Laboratories, Ltd. ( (JP:2395) ) just unveiled an announcement.

Shin Nippon Biomedical Laboratories has announced a leadership reshuffle, appointing Hideyuki Hirama as Representative President while long-serving leader Ryoichi Nagata will become Representative Chairman, effective after shareholder approval at the June 26, 2026 annual meeting. The move is aimed at strengthening the management structure to support sustainable medium- to long-term growth, and is accompanied by an expanded board slate, the promotion of Masato Nishie as a corporate officer, and the appointment of Naohiro Tsubaru as Honorary Senior Director.

Hirama brings experience from Mizuho Financial Group, SNBL USA, Gemseki Inc., and Rakuten Group’s Rakuten Symphony unit, indicating a push to blend financial, operational, and digital expertise in the next phase of the company’s development. The refreshed governance lineup, with both reappointed and newly appointed directors and officers, underscores SNBL’s intention to reinforce oversight and strategic capabilities as it pursues greater corporate value and potentially more competitive positioning in the biomedical services market.

The most recent analyst rating on (JP:2395) stock is a Buy with a Yen1780.00 price target. To see the full list of analyst forecasts on Shin Nippon Biomedical Laboratories, Ltd. stock, see the JP:2395 Stock Forecast page.

**More about Shin Nippon Biomedical Laboratories, Ltd.**

Shin Nippon Biomedical Laboratories, Ltd., listed on the TSE Prime, operates in the biomedical and pharmaceutical services sector. The company provides drug discovery and preclinical research-related services, positioning itself as a partner to pharmaceutical and life science firms seeking to advance R&D and enhance long-term corporate value.

**Average Trading Volume:** 224,483

**Technical Sentiment Signal:** Sell

**Current Market Cap:** Yen59.2B

See more insights into 2395 stock on TipRanks’ Stock Analysis page.

### Related Stocks

- [2395.JP](https://longbridge.com/en/quote/2395.JP.md)
- [8411.JP](https://longbridge.com/en/quote/8411.JP.md)
- [MFG.US](https://longbridge.com/en/quote/MFG.US.md)
- [4755.JP](https://longbridge.com/en/quote/4755.JP.md)

## Related News & Research

- [TABLE-Toyota Motor (7203.T) -2025/26 parent results](https://longbridge.com/en/news/285664989.md)
- [Oxford BioMedica shareholders adopt annual report, reappoint directors at AGM](https://longbridge.com/en/news/285901391.md)
- [Asahi Intelligence Service Updates Progress on Ongoing Share Buyback Program](https://longbridge.com/en/news/285701301.md)
- [Cobra Resources Corrects Total Voting Rights After Warrant Exercise](https://longbridge.com/en/news/285752922.md)
- [A Small Zipper, A Big Power: NOTAPE™ Reinvents the Zipper to Drive Breakthrough Innovation in Apparel](https://longbridge.com/en/news/285910071.md)